ANDREA WRIGHT: Open Payments
NPI 1386273217 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,108 in 64 payments from 11 companies in 2025. Trend: 2023 $1,250 · 2024 $1,306 · 2025 $2,108
Food & beverage: $2,096Education: $12
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $497 |
| Vanda Pharmaceuticals Inc. | 12 | $358 |
| ABBVIE INC. | 12 | $315 |
| Otsuka America Pharmaceutical, Inc. | 6 | $313 |
| Lundbeck LLC | 8 | $144 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $131 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Auvelity, REXULTI, FANAPT, VRAYLAR, AUSTEDO XR, COBENFY, INGREZZA, Qelbree.
Industry payments across WA — which companies pay providers there.
